Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07726862) titled 'How Healthy Adults Respond to the Nasal Flu Vaccine' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: University of Alabama at Birmingham
Condition:
Mucosal Immune Response to Influenza Vaccination
Intervention:
Biological: FluMist (Live Attenuated Influenza Vaccine)
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 1, 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials....